Viewing Study NCT01532869


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT01532869
Status: COMPLETED
Last Update Posted: 2016-09-23
First Post: 2012-02-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis
Sponsor: Hoffmann-La Roche
Organization: